← Evidence map

ArticleNature reviews. Gastroenterology & hepatology2025

New potent HBV replication inhibitors for the management of chronic hepatitis B are needed.

Timothy M Block et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39910374